United States Kyphoscoliosis Market is expected to reach US$ 1.4 billion by 2032 | Top Companies - Koninklijke Philips N.V., Canon, GE Healthcare

Market Size and Growth:

The Global Kyphoscoliosis Market Size reached US$ 2.9 billion in 2022 and is expected to reach US$ 4.2 billion by 2030, growing with a CAGR of 5.1% during the forecast period 2024-2031. The Market is growing due to rising prevalence of spinal deformities, increasing geriatric population, and advancements in corrective treatments and surgical interventions. According to DataM Intelligence Report.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/kyphoscoliosis-market?sz

The Kyphoscoliosis Market encompasses the diagnosis, treatment, and management of kyphoscoliosis, a spinal disorder characterized by abnormal curvature combining kyphosis and scoliosis. The market includes medical devices, surgical procedures, braces, physiotherapy solutions, and emerging therapies. Growth is driven by rising prevalence, technological advancements in spinal correction, and increasing awareness of early intervention for improved patient outcomes.

Industry Recent Developments: United States

✅ In November 2025, technological advancements in minimally invasive surgical procedures and robotic-assisted surgeries significantly enhanced treatment outcomes and recovery times for kyphoscoliosis patients.

✅ In October 2025, rising awareness campaigns and improved diagnostic tools, including AI-assisted diagnostics, contributed to early detection and better management of kyphoscoliosis cases.

✅ In September 2025, new biologics and pain management drugs entered the market, driving demand for personalized medical treatments and expanding therapeutic options for kyphoscoliosis.

Industry Recent Developments: Japan

✅ In November 2025, the integration of robotics and AI in spinal surgeries continued to advance, enabling greater precision in kyphoscoliosis treatment and improving patient recovery rates.

✅ In October 2025, government support for innovative medical device development and cross-border collaborations accelerated the adoption of cutting-edge kyphoscoliosis therapies in Japan.

✅ In September 2025, multicenter international clinical studies involving Japanese institutions focused on evaluating treatment efficacy for adults with kyphoscoliosis, with results expected by early 2026.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/kyphoscoliosis-market?sz

FDA / Regulatory Approvals & Developments in 2025:

Spinal Implants & Devices:

✅ The spinal implant market continues to grow strongly: Global spinal implant market projected to rise from ~ US$ 11.8 bn in 2024 to ~US$ 12.4 bn in 2025.

✅ A notable FDA clearance: Eminent Spine received 510(k) clearance in October 2025 for a 3D-printed titanium posterior SI (sacroiliac) system.

✅ From market‐reports: according to a forecast on the kyphoscoliosis‐treatment market, Stryker obtained FDA approval for 3D‐printed titanium spinal implants for severe kyphoscoliosis (reported in source covering 2024, but relevant to the 2025 market context).

Non‐Fusion / Growth Modulation Devices:

✅ The REFLECTTM Scoliosis Correction System (non-fusion device) is documented in its FDA "PAC Executive Summary" for 2025. The device uses polymeric cords and is designed to permit continued spinal growth.

✅ The MID‐C System, another internal brace (expandable rod) for spinal deformity, is cleared under a Humanitarian Use Device (HUD) designation. Its labeling and use criteria are described in the FDA's 2025 executive summary.

No New Pharmacological Approvals Specific to Kyphoscoliosis:

✅ A review of the FDA's list of Novel Drug Approvals in 2025 does not highlight any drugs specifically indicated for kyphoscoliosis.

✅ Given that kyphoscoliosis is primarily a structural/deformity disorder, its treatment market leans heavily on devices (surgical implants, bracing) rather than on drug therapies.

Mergers & Acquisitions (M&A) in 2025:

✅ Tyber Medical: Private equity firm Montagu agreed to acquire Tyber Medical in 2025, merging it with Intech and Resolve Surgical Technologies. Tyber is an orthopedic device manufacturer, and although not exclusively focused on kyphoscoliosis, its acquisition shapes the broader spine / orthopedic device ecosystem.

✅ Stryker Divestment: Stryker sold its U.S. spinal implants business to Viscogliosi Brothers, which plans to form a new company, VB Spine, to carry forward the spinal implants business.

Major Key Players:

Koninklijke Philips N.V.
Canon
GE Healthcare
Siemens
Hologic
Sri Krishna Pharmaceuticals Ltd
NEXGEN PHARMA INC
ValiantLabs.in.
BASF Corporation
Dr. Reddy's Laboratories Ltd.

Segments Covered in the Kyphoscoliosis Market:

By Type: Scoliosis, Kyphosis.

By Disease Management: Diagnosis, Medication, Surgery, Others.

By Age Group: Children, Adults.

By End User: Hospitals, Clinics, Ambulatory Surgical Centres.

Regional Analysis for Kyphoscoliosis Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=kyphoscoliosis-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Kyphoscoliosis market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Kyphoscoliosis Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Kyphoscoliosis market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Kyphoscoliosis Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Kyphoscoliosis market?

➠ Who are the global key manufacturers of the Kyphoscoliosis Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Kyphoscoliosis market opportunities and threats faced by the vendors in the global Kyphoscoliosis Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Kyphoscoliosis market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.